Mining and analysis of risperidone adverse event signals based on FAERS database

HUANG Ling; WANG Fengling; WANG Xinming; CHEN Li

doi:10.6039/j.issn.1001-0408.2023.03.18

您当前的位置：

首页 >

文章列表页 >

Mining and analysis of risperidone adverse event signals based on FAERS database

更新时间：2025-09-27

- Mining and analysis of risperidone adverse event signals based on FAERS database
- ZHONGGUO YAOFANG Vol. 34, Issue 3, Pages: 350-354(2023)
- 作者机构：
  
  1.成都医学院第一附属医院药学部，成都　610500
  2.四川大学华西第二医院药学部，成都　610041
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.03.18
  CLC： R969.3;R971
- Received：27 June 2022，
  
  Revised：2022-12-19，
  
  Published：15 February 2023
- 稿件说明：
移动端阅览
黄玲,王凤玲,陈力,等.基于美国FAERS数据库的利培酮不良事件信号挖掘与分析[J].中国药房,2023,34(03):350-354.

HUANG Ling,WANG Fengling,CHEN Li,et al.Mining and analysis of risperidone adverse event signals based on FAERS database[J].ZHONGGUO YAOFANG,2023,34(03):350-354.
黄玲,王凤玲,陈力,等.基于美国FAERS数据库的利培酮不良事件信号挖掘与分析[J].中国药房,2023,34(03):350-354. DOI： 10.6039/j.issn.1001-0408.2023.03.18.

HUANG Ling,WANG Fengling,CHEN Li,et al.Mining and analysis of risperidone adverse event signals based on FAERS database[J].ZHONGGUO YAOFANG,2023,34(03):350-354. DOI： 10.6039/j.issn.1001-0408.2023.03.18.

摘要

目的

为利培酮的临床安全使用提供参考。

方法

采用报告比值比法与英国药品和保健品管理局综合标准法，对美国FDA不良事件报告系统（FAERS）数据库中2017年第1季度至2021年第3季度共19个季度的利培酮相关药品不良事件（ADE）报告进行数据挖掘与分析。

结果

获得以利培酮为首要怀疑药物的ADE报告共计101 181份，涉及患者33 179例。所统计的报告中，男女比约为6.21∶1；以＜18岁的患者居多（占15.01%）；上报ADE者主要为消费者（占69.74%），上报国家主要为美国（占79.72%）；使用口服剂型的患者最多（占83.71%）。共产生ADE信号409个，包括男性乳腺发育、假性男性乳房发育症、体质量异常增加、高催乳素血症和Wellens综合征等；涉及26个系统器官分类，主要为生殖系统及乳腺疾病，各类损伤、中毒及操作并发症，精神病类，代谢及营养类疾病，各类神经系统疾病等。

结论

利培酮常见ADE信号及其累及系统器官与说明书基本一致，但也要警惕其说明书中未记载的ADE，如Wellens综合征、纤维增生性心内膜炎、门静脉海绵样变性、兔子综合征等。

Abstract

OBJECTIVE

To provide reference for safe use of risperidone in clinic.

METHODS

Data mining and analysis of risperidone-related adverse drug event （ADE） reports from the first quarter of 2017 to the third quarter of 2021 in the United States FAERS database were carried out using reported odds ratio and composite criteria methods from Medicines and Healthcare Products Regulatory Agency.

RESULTS

There were 101 181 ADE reports with risperidone as the primary suspect drug，involving a total of 33 179 patients. Among those reports，the male-to-female ratio was about 6.21 to 1； most of them were ＜18 years old （15.01%）； ADE was mainly reported by consumers （69.74%） and mainly reported by the United States （79.72%）； oral dosage form was the most used，accounting for 83.71%. A total of 409 ADE signals were obtained，including male breast development，pseudogynecomastia，abnormal increase in body mass，hyperprolactinemia and Wellens syndrome，etc. Twenty-six systems and organs were involved，mainly including reproductive system and breast diseases，various injuries，poisoning and operational complications，mental diseases，metabolic and nutritional diseases，and various nervous system diseases，etc.

CONCLUSIONS

The common ADE signals of risperidone and the system involved are consistent with the instructions，but we should also be alert to the ADE not recorded in the instruction，such as Wellens syndrome，fibroproliferative endocarditis，cavernous degeneration of portal vein，rabbit syndrome，etc.

关键词

Keywords

references

ARIAS D ， SAXENA S ， VERGUET S . Quantifying the global burden of mental disorders and their economic value [J ] . EClinicalMedicine ， 2022 ， 54 ： 101675 .

GERMANN D ， KURYLO N ， HAN F X . Risperidone [J ] . Profiles Drug Subst Excip Relat Methodol ， 2012 ， 37 ： 313 - 361 .

国家药品不良反应监测中心 . 药物警戒快讯 [J ] . 中国药物警戒， 2015 ， 12 （ 5 ）： 318 - 320 .

国家药品不良反应监测中心 . 药物警戒快讯 [J ] . 中国药物警戒， 2015 ， 12 （ 11 ）： 701 - 704 .

国家药品不良反应监测中心 . 药品不良反应信息通报：关注非典型抗精神病药的严重不良反应 [J ] . 中国药物警戒， 2016 ， 13 （ 4 ）： 253 - 254 .

国家药物不良反应监测中心 . 药物警戒快讯 [J ] . 中国药物警戒， 2015 ， 12 （ 4 ）： 254 - 256 .

加拿大卫生部 . 加拿大评估非典型抗精神病药与梦游和失眠相关饮食失调症的潜在风险 [J ] . 中国医药导刊， 2017 ， 19 （ 11 ）： 1249 .

TIEU C ， BREDER C D . A critical evaluation of safety signal analysis using algorithmic standardised MedDRA queries [J ] . Drug Saf ， 2018 ， 41 （ 12 ）： 1375 - 1385 .

王懿怡，陈力 . 基于FDA疫苗不良事件报告系统数据的人乳头状瘤病毒四价疫苗不良反应信号监测 [J ] . 医药导报， 2020 ， 39 （ 1 ）： 17 - 21 .

陈乾，陈力，程艺 . 基于美国FAERS数据库亮丙瑞林和戈舍瑞林不良反应信号检测 [J ] . 医药导报， 2020 ， 39 （ 10 ）： 1366 - 1374 .

RICHARD F ， LUIGI X C ， MICHELLE A C . 图解药理学：中文翻译版 [M ] . 罗俊，译. 北京：科学出版社， 2014 ： 137 - 142 .

CHOPKO T C ， LINDSLEY C W . Classics in chemical neuroscience：risperidone [J ] . ACS Chem Neurosci ， 2018 ， 9 （ 7 ）： 1520 - 1529 .

MÖLLER H J . Risperidone：a review [J ] . Expert Opin Pharmacother ， 2005 ， 6 （ 5 ）： 803 - 818 .

HUANG M L ， VAN PEER A ， WOESTENBORGHS R ， et al . Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects [J ] . Clin Pharmacol Ther ， 1993 ， 54 （ 3 ）： 257 - 268 .

KOMOSSA K ， RUMMEL-KLUGE C ， SCHWARZ S ， et al . Risperidone versus other atypical antipsychotics for schizophrenia [J ] . Cochrane Database Syst Rev ， 2011 ， 21 （ 1 ）： CD006626 .

LEE B H . The relationship between prolactin response and clinical efficacy of risperidone in acute psychotic inpatients [J ] . Prog Neuro Psychopharmacol Biol Psychiatry ， 2006 ， 30 （ 4 ）： 658 - 662 .

TURRONE P ， KAPUR S ， SEEMAN MV ， et al . Elevation of prolactin levels by atypical antipsychotics [J ] . Am J Psychiatry ， 2002 ， 159 （ 1 ）： 133 - 135 .

TROOST P W ， LAHUIS B E ， HERMANS M H ， et al . Prolactin release in children treated with risperidone：impact and role of CYP2D6 metabolism [J ] . J Clin Psychopharmacol ， 2007 ， 27 （ 1 ）： 52 - 57 .

LIU J H ， WANG P P ， SUN L L ， et al . The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients：a 12-week prospective study [J ] . Transl Psychiatry ， 2021 ， 11 （ 1 ）： 458 .

BROWN H K ， et al . Perinatal mental illness and maternal autoimmune disease：a review of current evidence and avenues for future research [J ] . Front Neuroendocrinol ， 2022 ， 65 ： 100975 .

Lexicomp Editorial Advisory Panel . Risperidone：drug information [EB/OL ] . [ 2022-10-16 ] . https：//www.uptodate.com/contents/risperidone-drug-information?search=%E5%88%A9%E5%9F%B9%E9%85%AE&source=panel_ search_result&selectedTitle=1~120&usage_type=panel& kp_tab=drug_general&display_rank=1 https://www.uptodate.com/contents/risperidone-drug-information?search=%E5%88%A9%E5%9F%B9%E9%85%AE&source=panel_search_result&selectedTitle=1~120&usage_type=panel&kp_tab=drug_general&display_rank=1 .

WANG Z X ， BRAUER R ， MAN K K C ， et al . Prenatal exposure to antipsychotic agents and the risk of congenital malformations in children：a systematic review and meta-analysis [J ] . Br J Clin Pharmacol ， 2021 ， 87 （ 11 ）： 4101 - 4123 .

ENNIS Z N ， DAMKIER P . Pregnancy exposure to olanzapine，quetiapine，risperidone，aripiprazole and risk of congenital malformations. A systematic review [J ] . Basic Clin Pharmacol Toxicol ， 2015 ， 116 （ 4 ）： 315 - 320 .

LARSEN ER ， DAMKIER P ， PEDERSEN LH ， et al . Use of psychotropic drugs during pregnancy and breast-feeding [J ] . Acta Psychiatr Scand Suppl ， 2015 ， 132 （ S445 ）： 1 - 28 .

KEITH S . Use of long-acting risperidone in psychiatric disorders：focus on efficacy，safety and cost-effectiveness [J ] . Expert Rev Neurother ， 2009 ， 9 （ 1 ）： 9 - 31 .

PEUSKENS J ， PANI L ， DETRAUX J ， et al . The effects of novel and newly approved antipsychotics on serum prolactin levels：a comprehensive review [J ] . CNS Drugs ， 2014 ， 28 （ 5 ）： 421 - 453 .

LOVE R C ， CONLEY R J . Long-acting risperidone injection [J ] . Am J Health Syst Pharm ， 2004 ， 61 （ 17 ）： 1792 - 1800 .

Views

699

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Pharmaceutical monitoring and analysis of a case of severe systemic allergic reaction caused by Wujia shenghua capsules during the postpartum period

Mining and analysis of adverse drug event signals related to mepolizumab

Pharmaceutical analysis for a patient with rebamipide-induced Stevens-Johnson syndrome by clinical pharmacists

我院1 557 例药品不良反应报告分析

我院1557例药品不良反应报告分析

Related Author

ZHAO Mingming

YE Yiqing

WU Shaoxing

LI Haoxuan

CHEN Yaoxin

XU Yinji

ZOU Jian

XU Han

Related Institution

Dept. of Pharmacy， Jilin Branch， Women’s Hospital， Zhejiang University School of Medicine

Dept. of Pharmacy， Women’s Hospital， Zhejiang University School of Medicine

The Second Clinical Medical College， Guangzhou University of Chinese Medicine

Dept. of Respiratory and Critical Care Medicine， Guangdong Provincial Hospital of Traditional Chinese Medicine

Dept. of Clinical Pharmacy，Pengzhou Municipal People’s Hospital， Sichuan Pengzhou

⁰